He added that the quinolones remain critical antibiotics for kidney transplant patients – and that the study in no way suggests that should change.
“We were using these daily for 3 months, and that’s where we got into the resistance trouble,” he said. “That’s not anything like a 7- to 10-day course for a urinary tract infection.”
Dr. Knoll reported receiving investigator-initiated research grants from Astellas Canada and Pfizer Canada. The other coauthors had a number of financial relationships with pharmaceutical companies.
On Twitter @alz_gal